July 19th 2024
Participants of the phase 3 trial for the Pfizer and Valneva vaccine candidate, VLA15, received their immunizations and everyone will be observed through next year’s Lyme disease season.
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Zika Linked to Second Neurological Disorder as NIAID Predicts Local Outbreaks
April 18th 2016According to the National Institutes of Health (NIH), the first case of locally transmitted Zika virus infection in the continental United States is now inevitable. The virus already brings with it fears for pregnant women, and those women trying to become pregnant, but now, a Zika virus infection is likely a risk for all adults as the virus has been linked to yet another neurological disorder.
Read More
Long-Term Antibiotics No Benefit for Chronic Lyme Disease Symptoms
April 6th 2016The results of a double-blind, randomized, placebo-controlled trial in patients with persistent symptoms of Lyme disease have shown that long-term antibiotic treatment does not lead to better outcomes than short-term antibiotic treatment does.
Read More
Insecticide-Treated Nets Prove to be Effective Malaria Control
April 5th 2016The findings of a new study reinforce the value of making insecticide-treated nets and indoor residual spraying of insecticides universally available—even in countries where the mosquitoes that transmit disease bite primarily outdoors.
Read More
CDC Officials Stress the Importance of Acting On Zika Before it Reaches the US
April 1st 2016The Centers for Disease Control and Prevention (CDC) held a Zika Action Plan Summit in Atlanta, Georgia today with the aims of preparing health officials of the possibility of local Zika transmission.
Read More
Researchers On the Verge of Identifying Biomarkers to Predict Dengue Disease Course
March 17th 2016An international team of researchers believes they may be on the verge of identifying biomarkers that can be used to predict disease course in dengue fever, thereby enabling clinicians to triage patients at higher risk for severe forms of the mosquito-borne infection at an earlier stage.
Read More
Local Zika Infections in Puerto Rico Prompt HHS and CDC to Take Initiative
March 11th 2016Fear of a Zika epidemic in Puerto Rico lead the HHS to initiate the transportation of "safe blood" to the island on March 5, 2016, two days before the CDC Director, Tom Frieden, MD, MPH, arrived there to evaluate the CDC's support for Zika response and inform residents about prevention methods.
Read More